Amedisys, Inc. – NASDAQ:AMED
Amedisys stock price today
$101
+11.04
+12.27%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in 2 days
Amedisys stock price monthly change
-8.29%
month
Amedisys stock price quarterly change
-8.29%
quarter
Amedisys stock price yearly change
-5.57%
year
Amedisys key metrics
Market Cap | 2.78B |
Enterprise value | 3.12B |
P/E | 22.28 |
EV/Sales | 1.40 |
EV/EBITDA | 13.12 |
Price/Sales | 1.17 |
Price/Book | 2.49 |
PEG ratio | -0.51 |
EPS | N/A |
Revenue | 2.25B |
EBITDA | 214.81M |
Income | -539K |
Revenue Q/Q | 2.70% |
Revenue Y/Y | 0.76% |
Profit margin | 5.34% |
Oper. margin | 8.13% |
Gross margin | 57.57% |
EBIT margin | 8.13% |
EBITDA margin | 9.54% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeAmedisys stock price history
Amedisys stock forecast
Amedisys financial statements
| Jun 2023 | 552.96M | -80.27M | -14.52% |
|---|---|---|---|
| Sep 2023 | 556.23M | 25.96M | 4.67% |
| Dec 2023 | 570.78M | 39.37M | 6.9% |
| Mar 2024 | 571.41M | 14.4M | 2.52% |
| Mar 2024 | 571.41M | 14.4M | 2.52% |
|---|---|---|---|
| Sep 2025 | 623.25M | 39.82M | 6.39% |
| Oct 2025 | 605.84M | 41.38M | 6.83% |
| Dec 2025 | 613.84M | 41.22M | 6.72% |
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 1982402000 | 921.64M | 46.49% |
|---|---|---|---|
| Sep 2023 | 2027417000 | 933.89M | 46.06% |
| Dec 2023 | 2060170000 | 940.38M | 45.65% |
| Mar 2024 | 2089871000 | 947.21M | 45.32% |
| Jun 2023 | 60.75M | -7.74M | -10.95M |
|---|---|---|---|
| Sep 2023 | -9.84M | -1.04M | -6.25M |
| Dec 2023 | 60.31M | -1.81M | -13.64M |
| Mar 2024 | -6.54M | -1.30M | -10.31M |
Amedisys alternative data
| Aug 2023 | 20,000 |
|---|---|
| Sep 2023 | 20,000 |
| Oct 2023 | 20,000 |
| Nov 2023 | 18,600 |
| Dec 2023 | 18,600 |
| Jan 2024 | 18,600 |
| Feb 2024 | 18,600 |
| Mar 2024 | 19,000 |
| Apr 2024 | 19,000 |
| May 2024 | 18,700 |
| Jun 2024 | 18,700 |
| Jul 2024 | 18,700 |
Amedisys other data
92.00%
+1.26%
of AMED is owned by hedge funds
276
-38
30.14M
+227.39K
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Jun 2022 | 0 | 557 |
| Mar 2023 | 0 | 5908 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Option | ASHWORTH RICHARD M director, officer.. | Common Stock | 11,237 | $79.82 | $896,937 | ||
Option | ASHWORTH RICHARD M director, officer.. | Stock Option (Right to Buy) | 11,237 | $79.82 | $896,937 | ||
Sale | NORTH MICHAEL PAUL officer: Chief Information Offi.. | Common Stock | 5,908 | $86.43 | $510,628 | ||
Option | KUSSEROW PAUL B. K. director, officer.. | Restricted Stock Unit (Performance-Based Vesting) | 5,777 | N/A | N/A | ||
Option | KUSSEROW PAUL B. K. director, officer.. | Common Stock | 5,777 | N/A | N/A | ||
Sale | BOHNERT DENISE M. officer: Chief Compliance Officer | Common Stock | 557 | $115 | $64,055 | ||
Sale | KEMMERLY DAVID L officer: Chief Le.. | Common Stock | 443 | $177.89 | $78,805 | ||
Sale | KEMMERLY DAVID L officer: Chief Le.. | Common Stock | 2,037 | $177.21 | $360,977 | ||
Sale | KEMMERLY DAVID L officer: Chief Le.. | Common Stock | 20 | $175.16 | $3,503 | ||
Option | KUSSEROW PAUL B. K. director, officer.. | Restricted Stock Units | 73,638 | N/A | N/A |
| Quarter | Transcript |
|---|---|
| Q4 2022 16 Feb 2023 | Q4 2022 Earnings Call Transcript |
| Q3 2022 27 Oct 2022 | Q3 2022 Earnings Call Transcript |
| Q2 2022 28 Jul 2022 | Q2 2022 Earnings Call Transcript |
| Q1 2022 28 Apr 2022 | Q1 2022 Earnings Call Transcript |
BrightSpring Health Services' Revenue Growth Flags Before IPO
Amedisys, Inc.: Why Stock Is A Hold Pending Agency Review
Amedisys: No Change To Thesis, Retain Hold
Enhabit: A Chip Off The Old Stock
Amedisys: Strategic Contessa Acquisition Underpins The Home Healthcare Growth Opportunity
Aveanna Healthcare - Home Care Play
-
What's the price of Amedisys stock today?
One share of Amedisys stock can currently be purchased for approximately $101.
-
When is Amedisys's next earnings date?
Unfortunately, Amedisys's (AMED) next earnings date is currently unknown.
-
Does Amedisys pay dividends?
No, Amedisys does not pay dividends.
-
How much money does Amedisys make?
Amedisys has a market capitalization of 2.78B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 0.59% to 2.24B US dollars.
-
What is Amedisys's stock symbol?
Amedisys, Inc. is traded on the NASDAQ under the ticker symbol "AMED".
-
What is Amedisys's primary industry?
Company operates in the Healthcare sector and Medical - Care Facilities industry.
-
How do i buy shares of Amedisys?
Shares of Amedisys can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Amedisys's key executives?
Amedisys's management team includes the following people:
- Mr. Paul Berthold Kusserow Chairman & Chief Executive Officer(age: 64, pay: $1,480,000)
- Mr. Christopher T. Gerard Pres, Chief Operating Officer & Director(age: 58, pay: $1,330,000)
- Mr. Scott G. Ginn Executive Vice President & Chief Financial Officer(age: 56, pay: $1,220,000)
- Mr. David L. Kemmerly Chief Legal & Gov. Affairs Officer(age: 62, pay: $849,030)
- Ms. Sharon Brunecz Chief HR Officer(age: 58, pay: $842,020)
-
How many employees does Amedisys have?
As Jul 2024, Amedisys employs 18,700 workers, which is 2% less then previous quarter.
-
When Amedisys went public?
Amedisys, Inc. is publicly traded company for more then 31 years since IPO on 17 Aug 1994.
-
What is Amedisys's official website?
The official website for Amedisys is amedisys.com.
-
Where are Amedisys's headquarters?
Amedisys is headquartered at 3854 American Way, Baton Rouge, LA.
-
How can i contact Amedisys?
Amedisys's mailing address is 3854 American Way, Baton Rouge, LA and company can be reached via phone at +225 2922031.
Amedisys company profile:
Amedisys, Inc.
amedisys.comExchange:
NASDAQ
Full time employees:
19,000
Industry:
Medical - Care Facilities
Sector:
Healthcare
Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The Personal Care segment provides assistance for patients with the activities of daily living. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care and palliative care to patients in their homes. As of December 31, 2021, the company owned and operated 331 home health care centers, 175 hospice care centers, and 14 personal-care, and 8 high acuity care centers in 38 states within the United States and the District of Columbia. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana.
3854 American Way
Baton Rouge, LA 70816
Baton Rouge, LA 70816
CIK: 0000896262
ISIN: US0234361089
CUSIP: 023436108
